Chr. Hansen’s latest launch secures rich flavor, more flexibility and consistent quality for the cheesemaker
Chr. Hansen reaches major milestone in innovation pipeline
Clinical trial demonstrates that probiotic strain strengthens the defense against gut damage caused by regular use of household painkiller
Klaus Bjerrum appointed new EVP of Natural Colors Division
Chr. Hansen Holding A/S has entered into an agreement with Klaus Bjerrum to take up the position of Executive Vice President of Natural Colors Division
New partnership to develop treatment for peanut allergies
Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.